Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
17 Nov 2026Kinetic Performance S.L.SpainEffects of Zynamite S on Fatigue, Mood, Sleep, Safety, and Tolerability in Healthy AdultsNot applicableCompleted17 Nov 2026Sinfatin S.LSpainStudy of the Effects of Rimonabant on Functional Recovery in Subacute Stroke PatientsPhase 2Not Yet Recruiting16 Nov 2026Aether Tech S.L.SpainAutomated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk TestNot applicableRecruiting13 Nov 2026DR Healthcare - biotexiaSpainEffect of Oral Diamine Oxidase on Symptoms Induced by Histamine Oral ChallengeNot applicableRecruiting12 Nov 2026Aether Tech S.L.SpainAutomated Versus Manual Oxygen Titration With the EMILY.AI Device in Hospitalized Patients With Acute Respiratory FailureNot applicableNot Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Sinfatin S.LSpainRimonabant for Cognitive Impairment in People With Post-COVID-19 SyndromePhase 2Not Yet Recruiting10 Nov 2026Boehringer IngelheimBelgium, France, GermanyA Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigPhase 3Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited States, Bulgaria, HungaryA Study of Brenipatide in Participants With Major Depressive DisorderPhase 2Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited States, France, JapanA Study of LY4336619 in Adult Participants With Advanced Solid TumorsPhase 1Not Yet Recruiting9 Nov 2026Boehringer IngelheimUnited States, Belgium, FinlandA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentPhase 2Not Yet Recruiting9 Nov 2026Boehringer IngelheimUnited States, Australia, JapanA Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D MutationPhase 1Not Yet Recruiting9 Nov 2026Femasys Inc.SpainA Study to Evaluate the Acceptability of the FemBloc System as a Non-surgical, Permanent Contraceptive MethodActive Not Recruiting9 Nov 2026FUSMobile Inc.SpainStudy Designed to Assess the Efficacy and Safety of the Neurolyser XR After Marketing ApprovalNot Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting3 Nov 2026Leukos Biotech S.L.SpainEvaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and LymphomaPhase 1Recruiting3 Nov 2026Sinfatin S.LSpainRimonabant for Improving Walking Ability in Patients With Chronic StrokePhase 2Not Yet Recruiting29 Oct 2026Genbioma Aplicaciones SLSpainEfficacy of the pA1c®HI Postbiotic in Metabolic Regulation in Healthy Individuals With HyperglycemiaEarly Phase 1Not Yet Recruiting29 Oct 2026Inmunotek S.L.Portugal, SpainSpecific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-069.Phase 3Recruiting29 Oct 2026Inmunotek S.L.Portugal, SpainSpecific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.Phase 3Recruiting29 Oct 2026SanofiSpainA Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Spain)Active Not Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting27 Oct 2026Swedish Orphan BiovitrumBrazil, Canada, FinlandA Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsPhase 3Recruiting26 Oct 2026CochlearSpainEffect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative TinnitusNot applicableNot Yet Recruiting20 Oct 2026Meiji Pharma Spain S.A.SpainPost-Market Clinical Follow-up of Intra-Articular Hyaluronic Acid in Hip OsteoarthritisRecruiting20 Oct 2026Mitra BioBelgium, Germany, SpainDevelopment and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestRecruiting// How AOS uses this